Exagen Inc. (XGN)

Exagen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	36.49	62.39	99.44	57.45	72.08
Cash & Cash Equivalents	36.49	62.39	99.44	57.45	72.08
Cash Growth	-41.51%	-37.26%	73.10%	-20.30%	447.58%
Receivables	6.55	6.08	9.65	8.91	5.72
Other Current Assets	4.8	4.14	3.64	4.16	3.45
Total Current Assets	47.84	72.61	112.73	70.52	81.25
Property, Plant & Equipment	8.49	13.08	4.77	2.1	1.38
Goodwill and Intangibles	0	0	5.51	5.51	5.51
Other Long-Term Assets	0.62	0.53	0.43	0.25	0.17
Total Long-Term Assets	9.1	13.61	10.71	7.86	7.06
Total Assets	56.94	86.22	123.45	78.38	88.31
Accounts Payable	3.13	3.05	2.49	3.01	1.48
Current Debt	1.24	1.23	0	0	0
Other Current Liabilities	7.53	5.35	6.83	5.76	4.42
Total Current Liabilities	11.9	9.62	9.32	8.77	5.9
Long-Term Debt	21.99	33.27	27.48	26.66	25.85
Other Long-Term Liabilities	0.36	0.87	1.71	1.11	0.9
Total Long-Term Liabilities	22.35	34.14	29.19	27.77	26.76
Total Liabilities	34.25	43.76	38.51	36.54	32.65
Total Debt	23.23	34.5	27.48	26.66	25.85
Debt Growth	-32.67%	25.56%	3.07%	3.11%	5.02%
Retained Earnings	-279.22	-255.53	-208.14	-181.29	-164.6
Shareholders' Equity	22.69	42.46	84.94	41.84	55.66
Net Cash / Debt	13.26	27.89	71.96	30.79	46.23
Net Cash / Debt Growth	-52.45%	-61.24%	133.73%	-33.40%	-
Net Cash Per Share	0.75	1.63	4.51	2.44	12.92
Working Capital	35.94	62.99	103.42	61.75	75.36
Book Value Per Share	1.28	2.49	5.32	3.31	15.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).